Tenet Healthcare Corp.’s
(THC) fourth-quarter loss narrowed as the hospital
operator saw improved results amid higher prices.
The company also projected a 2009 loss bigger than expectations,
, according to
Thomson Reuters. Revenue is seen rising to
$9 billion to $9.2 billion
, in line
with estimates, with admissions growth of as much as 1%. Last year’s admissions
increase was 1.2%.
Tenet, which has been struggling to gain its footing after Read the rest of this entry »

The gap in life expectancy between men and women is at its lowest level for more than 50 years. While both sexes are living longer, the latest figures released yesterday show that men are catching up with women.
Last night health experts said the change owed much to men smoking less, paying more attention to their diet and being less reluctant to go the doctor. Over 20 years, the gap between female and male life expectancy at birth has dropped Read the rest of this entry »

Akron, OH
Albuquerque, NM
Anaheim, CA
Anchorage, AK
Arlington, TX
Atlanta, GA
Aurora, CO
Austin, TX
Bakersfield, CA
Baltimore, MD
Baton Rouge, LA
Birmingham, AL
Boston, MA
Buffalo, NY
Chandler, AZ
Charlotte, NC
Chesapeake, VA
Chicago, IL
Chula Vista, CA
Cincinnati, OH
Cleveland, OH
Colorado Springs, CO
Columbus, OH
Corpus Christi, TX
Dallas, TX
Denver, CO
Detroit, MI
Durham, NC
El Paso, TX
Read the rest of this entry »

(RTTNews) - 
Wednesday, Cipher Pharmaceuticals Inc. (DND.TO:
) reported a narrower fourth-quarter loss, influenced by growing sales of Lipofen . The company also provided update on its extended-release formulation of tramadol.
Loss for the quarter narrowed to C$0.5 million or C$0.02 per share from C$1.6 million or C$0.07 per share in the corresponding period last year.
Licensing revenue advanced to $0.4 Read the rest of this entry »

(RTTNews) - 
Nyer Medical Group, Inc. (NYER:
) reported first-quarter net income from continuing operations of $55 thousands or $0.01 per share, compared to a net loss of $13 thousands or $0.01 per share in the same period of 2007.
Net loss for the quarter narrowed to $10 thousands from $35 thousands in the prior year quarter. On a per share basis, loss was $0.01, flat with a year ago.
Revenues for the quarter Read the rest of this entry »

(RTTNews) - 
Thursday, Escalon Medical Corp. (ESMC:
) reported a net loss for the first quarter of $481 thousand or $0.07 per share, narrower than $829 thousand or $0.13 per share in the year-ago quarter.
On non-GAAP basis, net loss narrowed to $164 thousand or $0.03 per share from $671 thousand or $0.11 per share in the same quarter last year.
Net revenues for the quarter increased to $8.69 million from $6.89 Read the rest of this entry »

(RTTNews) - 
Deltex Medical Group Plc (DEMG.L:
) reported first-half loss of GBP 1.12 million or 1.2 pence per share, compared to loss of GBP 1.17 million or 1.4 pence per share last year.
Pre-tax loss was GBP 1.13 million, narrower than GBP 1.19 million in the prior-year period.
The company’s half-yearly revenues grew to GBP 2.46 million from GBP 1.91 million in the comparable period a year ago.
The company Read the rest of this entry »

(RTTNews) - 
Inverness Medical Innovations, Inc. (IMA:
) said its loss for the third quarter narrowed from the prior year as revenues were driven by incremental revenues both from existing and acquired businesses. Earnings missed, while revenues were almost in line with, Street estimates.
Third-quarter loss for Inverness narrowed to $3.66 million or $0.12 per share from $180.61 million or $3.74 per share in the Read the rest of this entry »

(RTTNews) - 
Hansen Medical Inc. (HNSN:
) posted fourth quarter net loss of $14.9 million or $0.59 per share, compared to a net loss $23.9 million or $1.10 per share in the year-ago quarter.
Revenues for the quarter increased to $7.3 million from $4.2 million in the prior year quarter.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.53 per share on revenues of $9.04 million. Read the rest of this entry »

(VEC.LN) Monday
reported a narrower net loss and said it expects further payments from its big
pharmaceutical partners over the next year as its drugs move through
development.
Sept. 30
GBP13.3 million
, up
from
GBP12.3 million
a year earlier. The net loss narrowed to
GBP9.98 million
GBP10.1 million
despite higher research and development costs.
Baxter International Inc.’s
(BAX) hemophilia treatment Advate,
product and technology Read the rest of this entry »